Blogs
Emphasize academic exchange and strive for product optimization.

The first product exchange meeting of Taoshang Medical and Jinweite Medical was successfully held

2024-09-23

Author:

1727249480912998.jpg

Good news: Taoshang Medical's first mobile CT, "Lingtong," obtained its registration certificate from the National Medical Products Administration on September 3rd, officially entering the market and adopting a global marketing model. While sharing this joy, we also recognize the enormous business opportunities in China's health industry, driven by an aging population, rising living standards, and changing lifestyles. From September 23rd to 24th, Taoshang Medical and Jinweite Medical jointly held the first product symposium, inviting domestic and international distributors interested in cooperation to discuss product technology, advantages, cooperation methods, and marketing concepts.

1727249622266416.jpg

Mr. Xiao Jia Yi, founder of Taoshang Medical & Jinweite Medical, Doctor of Economics, vice president of Hunan Association of Small and Medium-sized Enterprises, and council member of Hunan Pharmacological Society, delivered the opening remarks. He pointed out that mobile CT differs from traditional CT. Combining the significant advantages of mobile CT—bedside, vehicle-mounted, and portable—future sales models will extend beyond traditional hospital channels to include military bases, physical examination institutions, corporate clients, overseas exports, and pet hospitals, among others, through a multi-faceted, downward sales model.

1727249664725949.jpg

1727249683444228.jpg

(Company showroom and equipment workshop visit and exchange)

On September 23rd, Taoshang's technical director, product manager, and sales director presented on the core topics of mobile CT technological advantages, mobile medical services, and empowerment of primary-level medical enterprises. On the 24th, Jinweite Medical's product R&D director and product manager gave presentations and discussions on interventional technology, vascular diseases, and coronary artery access consumables. The two-day symposium concluded successfully, with participants sharing their successful experiences and innovative ideas. Each in-depth conversation and exchange of ideas reinforced our belief in the boundless potential of the health industry. Looking ahead, we will continue to uphold the principles of openness, cooperation, and mutual benefit, working hand-in-hand with our partners to seize new opportunities, meet new challenges, and create new glories.